Creso Pharma Brings Together Cannabis Experts Across Several Verticals
Ryan Allway December 18th, 2018 Exclusive, Top News The due diligence process looks very different for small-cap versus large-cap stocks. When analyzing large-cap companies, investors pay closest attention to financial statements and valuation ratios to extrapolate growth rates and apply multiples. Small-cap stocks tend to be earlier stage... Read more
Wiz Khalifa Partners with Supreme to Expand Cannabis Brand
Ryan Allway December 18th, 2018 Exclusive, News, Press Releases, Top News The music industry has become increasingly intertwined with the cannabis industry over the past several years. With the partnership between Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Snoop Dogg in 2016, these relationships grew even closer... Read more
Wayland Announces Significant Supply Agreement with RavenQuest BioMed
TORONTO, Dec. 18, 2018 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) and RavenQuest BioMed Inc. (“RavenQuest”) are pleased to announce the companies have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in... Read more
Grown Rogue Launches Craft Cannabis Chocolates
Ryan Allway December 14th, 2018 Uncategorized Cannabis and chocolate have a long history together. While “pot brownies” are perhaps the original cannabis edible, professional chefs and food scientists have refined the process of infusing cannabinoids and chocolates to create unique innovations. Investors may want to take a closer... Read more
Canntab Partners with Leading Surgeon to Conduct Pain Management Trial
Ryan Allway December 14th, 2018 Exclusive, Top News The opioid industry is expected to generate nearly $20 billion in annual revenue by 2020, but the addictive nature of the drug has doctors and patients increasingly concerned. With the legalization of cannabis across Canada and many U.S. states, there’s... Read more
Blockchain Technology Offers a Solution to Cannabis Quality Control
Ryan Allway December 14th, 2018 Exclusive, News, Top News The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, following the legalization of adult-use cannabis earlier this year. While early sales have been brisk, the industry faces key challenges with safety... Read more
Aleafia Health: A New LP with 22 Medical Clinics, 50K Patients and 98,000 kg Production
Ryan Allway December 14th, 2018 Exclusive, News, Top Story The Canadian cannabis market is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. While many companies are focused on supplying the recreational market, the medical market may... Read more
Grown Rogue Wins Highest THC % and Highest Terpenes % at Grow Classic
MEDFORD, OR, USA, December 7, 2018 /EINPresswire.com/ — Grown Rogue took home top honors from the Grow Classic held in Eugene, OR last weekend. The company was one of 31 elite growers from across the state of Oregon who entered the three-category competition, in which Grown Rogue took first... Read more
Canntab Enters Into a Binding Term Sheet With Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D. for a Clinical Research Trial of Canntab’s Tablets
Ryan Allway December 5th, 2018 Partnership formed with Dr. Don Garbuz, an award winning orthopaedic surgeon and medical researcher, credited with over 120 peer reviewed publications. The parties will seek to conduct a clinical study with orthopaedic patients, using Canntab’s sustained release tablets. The study aims to show... Read more
FSD Pharma Congratulates Partner Canntab on Launch of Research Partnership with Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D.
– FSD Pharma to work with Canntab to create tablets for the clinical research study at its facility in Cobourg, Ontario, Canada – FSD Pharma Inc. (“FSD Pharma”) (HUGE.CN) (FSDDF) (0K9.F) today congratulated strategic partner Canntab Therapeutics Limited (“Canntab”) (CSE:PILL) (TBF1.F) on the launch of a research partnership with... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )